Clinical Trials
100 trialsRAMPART
Montefiore Medical Center
TraveraRTGx
Travera Inc
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
FAISA-CORPPS
University Hospital, Lille
Evaluations of Alcohol Warning Labels
University of Connecticut
EARN
Washington University School of Medicine
KEYVIBE-005
Merck Sharp & Dohme LLC
DELFI-L101
Delfi Diagnostics Inc.
A Study of CDX-585 in Patients With Advanced Malignancies
Celldex Therapeutics
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
NGM Biopharmaceuticals, Inc
ABIMMUNE
Gustave Roussy, Cancer Campus, Grand Paris
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
PREFER
Labcorp Corporation of America Holdings, Inc
MOM
Inova Health Care Services
ACTolog
Immatics US, Inc.
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
BeiGene
ROOT
Taproot Health
A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Symphogen A/S
Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies
TopAlliance Biosciences
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
Covenant Health Cancer Center
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Jacobio Pharmaceuticals Co., Ltd.
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Radiogenomics in Aerodigestive Tract Cancers
Buddhist Tzu Chi General Hospital
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
CytomX Therapeutics
MORRIS
Umeå University
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
Celldex Therapeutics
Adaptive Pet Study
Duke University
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
Instituto do Cancer do Estado de São Paulo
A Study of PRT1419 in Patients With Advanced Solid Tumors
Prelude Therapeutics
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Quadriga Biosciences, Inc.
A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Ludwig Institute for Cancer Research
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Incyte Corporation
DETECT
Boryung Pharmaceutical Co., Ltd
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
MacroGenics
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Weill Medical College of Cornell University
First-in-human Study of S-588210 (S-488210+S-488211)
Shionogi Inc.
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
Seagen Inc.
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
Incyte Corporation
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
Seagen Inc.
DRIHNC - Dehydration Reduction in Head & Neck Cancer
Case Comprehensive Cancer Center
Investigator Initiated Phase 1 Study of TBI-1201
Mie University
PCA062 in pCAD-positive Tumors.
Novartis
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies
Incyte Corporation
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer
King Chulalongkorn Memorial Hospital
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Osaka University
To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
Zhujiang Hospital